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Palmitate Activates Insulin Signaling Pathway in
Pancreatic Rat Islets
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Objective: To investigate the action of palmitate on insulin receptor
(IR) signaling pathway in rat pancreatic islets. The following proteins
were studied: IR substrate-1 and -2 (IRS1 and IRS2), phosphatidylinositol
3-kinase, extracellular signalYregulated protein kinase-1 and -2 (ERK1/2),
and signal transducer and activator of transcription 3 (STAT3).
Methods: Immunoblotting and immunoprecipitation assays were used
to evaluate the phosphorylation states of IRS1 and IRS2 (tyrosine [Tyr]),
ERK1/2 (threonine 202 [Thr202]/Tyr204), and STAT3 (serine [Ser727]).
Results: The exposure of rat pancreatic islets to 0.1-mmol/L palmitate
for up to 30 minutes produced a significant increase of Tyr phospho-
rylation in IRS2 but not in IRS1. The association of phosphatidyl-
inositol 3-kinase with IRS2 was also upregulated by palmitate. Exposure
to 5.6-mmol/L glucose caused a gradual decrease in ERK1/2 (Thr202/
Tyr204) and STAT3 (serine [Ser727]) phosphorylations after 30-minute
incubation. The addition of palmitate (0.1 mmol/L), associated with
5.6-mmol/L glucose, abolished these latter effects of glucose after
15-minute incubation.
Conclusions: Palmitate at physiological concentration associated with
5.6-mmol/L glucose activates IR signaling pathway in pancreatic A cells.
Key Words: pancreatic islets, palmitate, insulin receptor signaling,
IRS2, ERK1/2, STAT3
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Short-term exposure (1 hour) of pancreatic islets to freefatty acids (FFAs) increases glucose-stimulated insulin se-
cretion (GSIS) at high glucose concentration (16.7 mmol/L).1Y3
However, islet exposure to palmitate for a prolonged period
(24 hours) shows low GSIS.4,5 The potentiation of GSIS is as-
sociated with inhibition of FFA oxidation, increased FFA ester-
ification, and complex lipid synthesis by pancreatic A cells.6
Pancreatic islets convert glucose into fatty acids, and a substan-
tial amount of them is released to extracellular medium after
60-minute static incubation.7 The exported FFAs probably have
an important paracrine function, amplifying GSIS. Despite this,
the precise mechanisms by which FFA modulate insulin release
by pancreatic A cell are not fully understood yet.
Evidence exists that the autocrine action of insulin through
insulin/insulin<like growth factor-1 receptor pathway is involved
in maintaining A cell mass and function.8Y12 Insulin receptor
substrate-2 induces proliferation of pancreatic A cells and pro-
tects them from apoptosis induced by chronically elevated glu-
cose concentrations.13 Extracellular signalYregulated protein
kinase-1 and -2 (ERK1/2) and signal transducer and activator
of transcription 3 (STAT3) also play an important role for pan-
creatic A cell survival and growth. In cultured islets, the phar-
macological inhibition of ERK1/2 considerably reduced A cell
proliferation.14 Signal transducers and activators of transcrip-
tion are cytoplasmic transcription factors activated by tyrosine
(Tyr) phosphorylation and dimerization.15 Signal transducer and
activator of transcription 3 is activated by a variety of growth
factors, cytokines, and hormones and plays a critical role in
proliferation and survival of pancreatic A cells.16,17
Our previous results revealed an increase in insulin re-
ceptor (IR) protein content and its tyrosyl phosphorylation in
isolated rat pancreatic islets exposed to 0.1-mmol/L palmitate
and 5.6-mmol/L glucose for 30 minutes. This effect was asso-
ciated with protein palmitoylation but not to fatty acid oxi-
dation.18 This was the first evidence for the action of fatty acids
on insulin signaling pathway in pancreatic islets.
In the present report, we studied the short-term effect (up
to 30 minutes) of palmitate on IR signaling pathway in rat
pancreatic islets. Palmitate increased IR substrate-2 (IRS2)
tyrosyl phosphorylation and its association with phosphatidy-
linositol 3-kinase (PI3K) and delayed ERK1/2 and STAT3
dephosphorylations observed in the presence of 5.6-mmol/L
glucose.
MATERIALS AND METHODS
Reagents
Reagents for sodium dodecyl sulfateYpolyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotting were ob-
tained from Bio-Rad (Richmond, Calif). Trizma, aprotinin,
dithiothreitol, Triton X-100, glycerol, Tween 20, and sodium
palmitate were obtained from Sigma (St Louis, Mo). Protein
A Sepharose 6 MB was obtained from Pharmacia (Uppsala,
Sweden). The immunoblot enhanced chemiluminescence de-
tection kit was from Amersham Pharmacia Biotech (Buckin-
ghamshire, UK), and the nitrocellulose membrane (0.45 Km)
was from Bio-Rad (Hercules, Calif). Antiphosphotyrosine,
anti-IRS1, and anti-IRS2 antibodies were from Santa Cruz Bio-
technology (Santa Cruz, Calif); anti-p44/42 and antiYphospho-
p44/42 (Thr202/Tyr204) mitogen-activated protein kinases
(MAPKs), anti-STAT3, and antiYphospho-STAT3 (serine 727
[Ser727]) antibodies were from Cell Signaling Technology (St
Louis, Mo); anti-PI3K p85 was from Upstate Biotechnology
(Lake Placid, NY); and antiYA-actin was from Zymed Laborato-
ries (San Francisco, Calif).
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The anti-p44/42 and antiYphospho-p44/42 (Thr202/
Tyr204) MAPKs, anti-PI3K p85, and antiYA-actin antibodies
were used at 1:1000 dilution. The antiphosphotyrosine, anti-
phospho-STAT3 (Ser727), and anti-STAT3 antibodies were used
at dilutions of 1:400.
Animals
Female albino rats weighing 250 to 300 g were kept under
standard lighting conditions (12-hour lightYdark cycle) at a tem-
perature of 23 T 1-C, in groups of 5, and were allowed access to
standard rodent chow and water ad libitum. The study was ap-
proved by the Ethical Committee of the Institute of Biomedical
Sciences, University of Sao Paulo.
Isolation of Pancreatic Islets
Islets were isolated by collagenase digestion of the pan-
creas after the method previously described by Lacy and
Kostianovsky.19 Krebs-Henseleit buffer containing 115-mmol/L
NaCl, 5-mmol/L KCl, 24-mmol/L NaHCO3, 1-mmol/L CaCl2,
and 1-mmol/L MgCl2 was used for pooling the islets.
Immunoblotting
Groups of 300 islets were incubated at 37-C in Krebs-
Henseleit buffer containing 5.6-mmol/L glucose equilibrated
with a mixture of 95% O2/5% CO2, pH 7.4, in the absence or
presence of 0.1 mmol/L palmitate for 30 minutes. Palmitic acid
was dissolved in ethanol before addition into the incubation
medium to form an emulsified fatty acid solution. The final
ethanol concentration in this fatty acid solution was 0.5%.
Preliminary experiments established that 0.5% ethanol has no
effect on basal insulin release.3 At the end of the experiments,
the islets were transferred to a tube containing 80 KL of ex-
traction buffer (100-mmol/L Trizma, 1% SDS, 100-mmol/L so-
dium pyrophosphate, 100-mmol/L sodium fluoride, 10-mmol/L
EDTA, and 10-mmol/L sodium orthovanadate). They were ho-
mogenized using an ultrasonic processor (Sonics & Materials,
Newtown, Pa) and boiled for 10 minutes. The extracts were then
centrifuged at 12,000 rpm at 4-C for 20 minutes to remove
insoluble material. Protein determination in the supernatants
was performed by the Bradford dye method using the Bio-Rad
reagent.20
The whole extracts were treated with Laemmli sample
buffer containing dithiothreitol and boiled for 5 minutes before
loading onto 8% or 10% SDS-PAGE in a Bio-Rad miniature slab
gel apparatus. Similar-sized aliquots (between 60 and 80 Kg)
were subjected to SDS-PAGE. The electrotransfer of proteins
from the gel to the nitrocellulose membrane was performed
for 1.5 hours at 120 V (direct current) in a Bio-Rad miniature
transfer apparatus. Non-specific protein binding to the nitrocel-
lulose membrane was reduced by preincubation for 2 hours
at 22-C in blocking buffer (5% nonfat dry milk, 10-mmol/L
Trizma, 150-mmol/L NaCl, and 0.02% Tween 20). The nitro-
cellulose membranes were incubated overnight at 4-C with
antibodies diluted in blocking buffer with 3% nonfat dry milk
and then washed for 30 minutes. The membranes were subse-
quently incubated with peroxidase-conjugated secondary anti-
body for 1 hour and processed for enhanced chemiluminescence
to visualize the immunoreactive bands. Band intensities were
quantified by optical densitometry (Scion Image-Release Beta
3b; National Institutes of Health, Bethesda, Md) of the devel-
oped autoradiographs.
Immunoprecipitation Assay
For immunoprecipitation followed by immunoblot anal-
ysis, groups of 500 pancreatic islets were exposed to the exper-
imental conditions described previously. Equal amounts of the
supernatant of the whole extracts were used in immunoprecip-
itation experiments. The composition of the extraction buffer
was 100-mmol/L Trizma, 100-mmol/L sodium pyrophosphate,
100-mmol/L sodium fluoride, 10-mmol/L EDTA, 10-mmol/L
sodium orthovanadate, 2-mmol/L phenylmethylsulfonyl fluoride
(PMSF), 0.01-mg/mL aprotinin and 1% Triton X-100. The
samples were incubated with anti-IRS1 or IRS2 antibodies at
4-C overnight, followed by addition of Protein A Sepharose
6 MB for 2 hours. The pellets were repeatedly washed in buffer,
resuspended in 50 KL of Laemmli sample buffer and boiled
for 5 minutes before loading onto the gel.
Caspase 3 Activity
The J774 murine macrophage cell line was used as a
positive control for caspase activity assay in incubation with
1-Kmol/L staurosporine, a proapoptotic agent, for 6 hours.
J774 cells were grown in RPMI<1640 medium containing 10%
fetal calf serum. This medium was supplemented with glutamine
(2 mmol/L), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES; 20 mmol/L), streptomycin (10,000 Kg/mL), penicillin
(10,000 UI/mL), and sodium bicarbonate (24 mmol/L). The
cells were kept in a humidified atmosphere containing 5%
CO2 at 37 -C.
The J774 cells were centrifuged at 1000 g for 15 minutes
at 4-C. The pellet of cells or the samples with 200 islets
were resuspended in 200 KL of lyse buffer containing 10%
sucrose, 0.1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-
propanesulfonate, 100-mmol/L HEPES, pH 7.4, 10-mg/mL
leupeptin, 10-mg/mL aprotinin, 200-mmol/L PMSF, and 10-
mmol/L dithiothreitol. The samples were incubated for 30
minutes at 4-C and centrifuged at 12,000 g for 30 minutes at
4-C. The supernatant was collected, and protein was determined
by Bradford.20 Caspase protease activity was determined by
incubating the lysate (20 Kg of total protein) with 50 Kmol/L of
the fluorogenic caspase 3 substrate AC-DEVD-AMC (ac-Asp-
Glu-Val-Asp-AMC) in the buffer (10% sucrose, 100-mmol/L
HEPES, pH 7.4, 10-mg/mL leupeptin, 10-mg/mL aprotinin,
200-mmol/L PMSF, and 10-mmol/L dithiothreitol). The caspase
activity was assessed by measuring the fluorescence of Asp-
7-amino-4-trifluoromethyl coumarin released for 30 minutes
at 5-minute intervals by using a spectrofluorometer (Spectra
MAX Gemini XS; Molecular Devices, Sunnyvale, Calif).21
Statistical Analysis
Results are presented as means (SEM). Comparisons be-
tween groups were performed using analysis of variance. Sig-
nificant differences were assessed by using the Tukey-Kramer
test (InStat; GraphPad Software, Inc, San Diego, Calif). Student
unpaired t test was used for a comparison between only 2
groups. The level of significance was set to P G 0.05.
RESULTS
Insulin Receptor Substrate-2 Phosphorylation
and Association With PI3K Was Upregulated
by Palmitate
Palmitate induced a significant increase in Tyr phosphory-
lation of IRS2 but not of IRS1 (Figs. 1A, B). Phosphatidyl-
inositol 3-kinaseYIRS2 association was increased by the fatty
acid, but the PI3K/IRS1 association remained unchanged
(Figs. 1C, D). The increment of tyrosyl phosphorylation was
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not caused by a raise in the amount of IRS2, which remained
constant during the experiments (Figs. 1E, F).
Palmitate Delayed the Decrease in ERK1/2 and
STAT3 Phosphorylations Observed in Incubation
With 5.6-mmol/L Glucose
The pancreatic islets incubated in the presence of 5.6-
mmol/L glucose showed ERK1/2 dephosphorylation after
15 minutes. The addition of palmitate into the medium induced
a delay of ERK dephosphorylation, which was detected only
after 30 minutes of incubation (Figs. 2A, B). As observed for
ERK1/2 phosphorylation, palmitate also induced a delay in the
dephosphorylation of STAT3 (Ser727) during 30 minutes
(Figs. 2C, D). The phosphorylation levels of ERK1/2 and
STAT3 after 30-minute incubation did not differ between the
2 conditions (data not shown). However, distinct of that detected
in the ERK proteins levels, which remained unchanged
(Figs. 2A, B), there was a decreased level of STAT3 protein
along the time course incubation with glucose or in association
with the fatty acid (Figs. 2E, F).
FIGURE 1. Effect of palmitate on Tyr phosphorylation and association of IRS1/2 with PI3K. Palmitate induced Tyr phosphorylation of
IRS2 (A) but not of IRS1 (B) and increased the association of the p85 subunit of PI3K to IRS2 (C) with no alteration of its association with IRS1
(D) in isolated rat pancreatic islets. The contents of IRS2 (E) and IRS1 (F) were not altered by the fatty acid. Groups of 500 islets were
incubated with 5.6-mmol/L glucose (white bars) or with 5.6-mmol/L glucose and 0.1-mmol/L palmitate (black bars) for 30 minutes.
The islets were homogenized in extraction buffer, and after centrifugation, aliquots with the same amount of proteins were
immunoprecipitated (IP) with anti-IRS2 or anti-IRS1 and immunoblotted (IB) with antiphosphotyrosine, PI3K/p85, IRS1, or IRS2
antibodies. The bars represent the relative phosphorylation or protein expression as determined by optical densitometry and are
presented as mean (SEM) of 4 experiments. *P G 0.05 and ***P G 0.001 as compared with 5.6-mmol/L glucose.
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FIGURE 2. Time course effect of palmitate and 5.6-mmol/L glucose on ERK1/2 and STAT3 phosphorylations. The bars express the time
course of phosphorylation of ERK1/2 (Thr202/Tyr204; A and B) and STAT3 (Ser727; C and D) and the content of STAT3 (E and F)
during 0- to 30-minute incubation of isolated rat pancreatic islets. Groups of 300 islets were incubated with 5.6-mmol/L glucose
(white bars) or with 5.6-mmol/L glucose and 0.1-mmol/L palmitate (black bars) for different periods. The bars represent the relative
phosphorylation or protein expression as determined by optical densitometry and are presented as mean (SEM) of 3 experiments.
*P G 0.05, **P G 0.01, and ***P G 0.001 compared with 0-minute time, the initial incubation period. G, Insulin signaling pathway
activated by palmitate in pancreatic islets: the increase in IR Tyr phosphorylation by palmitate as previously demonstrated18 induced an
increase in Tyr phosphorylation of IRS2, which is associated with PI3K activation. Insulin receptor substrate-2 tyrosyl phosphorylation
induced by palmitate also activated the ERK/STAT3 pathway. Potentialization of ERK activity could also be a result of down-regulation of
phosphatase activity, improving STAT3 serine phosphorylation.
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Palmitate Did Not Change Caspase 3 Activity
The activity of caspase 3, an early apoptotic event, was
not raised by exposure of pancreatic islets to palmitic acid for
30 minutes (Fig. 3).
DISCUSSION
Palmitate induced a significant increase in IRS2 Tyr phos-
phorylation (Fig. 1A) that was not caused by the raise in the
amount of this protein (Fig. 1E). This fact suggests that palmi-
tate at physiological concentration range, and in the presence of
5.6-mmol/L glucose, regulates IR-activated pathways in pancre-
atic islets via IRS2.
Insulin receptor substrate-2 phosphorylation activates at
least two A-cell signaling pathways: the PI3K and the
MAPK.22,23 Palmitate induced IRS2 phosphorylation (Fig.
1A), its association with PI3K (Fig. 1C), and delayed ERK1/2
(Figs. 2A, B) and STAT3 (Figs. 2C, D) dephosphorylations in
the presence of 5.6-mmol/L glucose (Fig. 2G). These findings
support the proposition that short-time exposure to palmitic acid
raises pancreatic A cell survival. Simon et al24 have shown that
short-period exposure to fatty acids is not enough to induce
cytotoxicity in pancreatic A cells because survival pathways are
activated. Therefore, palmitate is an important modulator of
pancreatic islet function.
In the presence of 5.6-mmol/L glucose, glucose oxidation
is decreased in the presence of palmitate,3 probably because of
a reduction in the flux of substrates through the tricarboxylic
acid cycle. Under this condition, there is an increase in palmitate
oxidation and also in its incorporation into lipid fractions,
mainly phospholipids and triacylglycerols in pancreatic islets.3
Insulin receptor substrate-2 tyrosyl phosphorylation acti-
vates MAPK/STAT3 pathway through association with growth
factor receptorYbound protein-2 coupled to the mammalian Son
of Sevenless, which activates Ras. This latter protein activates
Ser/Thr protein kinase Raf-1 that phosphorylates MAP/ERK
kinase, leading to ERK1/2 phosphorylation.25 Extracellular
signalYregulated protein kinase, a well-studied MAPK, is stim-
ulated by growth factors,26,27 and a prolonged activation of
ERK1/2 and PI3K signaling pathways is important in commit-
ting A cell to mitogenesis.22
As described by Costes et al,28 the treatment of islets with
high glucose concentration (16.7 mmol/L) induced a transient
phosphorylation of ERK1/2 and rapid dephosphorylation that
could be associated with the isolation procedure. The addition of
palmitate delayed ERK dephosphorylation observed in the
presence of 5.6-mmol/L glucose (Figs. 2A, B). Therefore, the
addition of a physiological concentration of fatty acid in asso-
ciation with basal glucose concentration could attenuate this
spontaneous dephosphorylation. One downstream pathway of
ERK1/2 activation is the serine phosphorylation of STAT3,
which is activated by dual phosphorylation (Tyr705 and Ser727).
Tyrosine 705 phosphorylation is required for cytokine-induced
STAT3 dimerization, nuclear translocation, and DNA binding.
However, full transcriptional activity of the homodimer
is manifested only when Ser727 in the transactivation domain
is also phosphorylated.29 Extracellular signalYregulated protein
kinases modulate the transcriptional activity of STAT3 by phos-
phorylation at Ser727.30Y32 After phosphorylation, STAT3
migrates to the nucleus to exert its effects on a transcriptional
regulation level. In this scenario, one hypothesis to be con-
sidered is that the detected decrease in STAT3 protein level after
30-minute incubation in the presence of 5.6-mmol/L glucose
and 0.1-mmol/L palmitate (Figs. 2E, F) could be caused by the
degradation of this transcription factor.
On the other hand, the decreased phosphorylation of ERK
(Figs. 2A, B), with no modification of ERK protein level, may
be associated with the regulation of the phosphorylation state of
the molecule through phosphatase activity. Serine-phosphatases,
tyrosine-phosphatases, or dual-specificity phosphatases can reg-
ulate MAPK in vivo.33,34 The delayed ERK dephosphorylation
by the fatty acid in pancreatic islets (Fig. 2B) may represent a
down-regulation of these phosphatases, producing a potentiali-
zation of this pathway.
The delay of ERK dephosphorylation induced by palmitate
might enhance STAT3 serine phosphorylation (Figs. 2C, D),
controlling its transcriptional activity. Signal transducer and
activator of transcription 3 upregulates the expression of sev-
eral genes involved in cell cycle progression35,36 such as cyclin
D, c-myc, and/or pim-1 and of anti-apoptotic genes such as Bcl-2
and Bcl-XL.37 The expression of a constitutively activated form
of STAT3 in pancreatic A cells is associated with normal
islet morphology and glucose-induced early-phase insulin
secretion.16,38 These observations indicate the importance of
this transcriptional factor for maintenance of pancreatic A cell
mass and function.
FIGURE 3. Effects of 0.1-mmol/L palmitic acid and 1-mmol/L staurosporine on caspase 3 activity. A, The activity of caspase 3 in pancreatic
islets after treatment for 30 minutes with 5.6-mmol/L glucose (5.6) and addition of 0.1-mmol/L palmitic acid (5.6 Palm) is shown.
B, For positive control, caspase 3 activity was measured in J774 murine macrophage cell line incubated with 1-Kmol/L staurosporine for
6 hours. Protease activity was determined by incubating concomitantly the lysates of islets and J774 cells (20 Kg of total protein) with
50-Kmol/L of the fluorogenic substrate AC-DEVD-AMC in the lyse buffer. Caspase activity was assessed by measuring fluorescent
Asp-7-amino-4-trifluoromethyl coumarin released for 30 minutes at 5-minute intervals by using a spectrofluorometer. The values are
presented as mean (SEM) of 3 experiments. **P G 0.01 for comparison between the treatment with staurosporine and control.
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Long-chain saturated fatty acid molecules such as palmitate
cause apoptosis of pancreatic islets, producing activation of
caspase 3 after 24 hours.39 However, under physiological and
short time exposure, palmitate did not change caspase 3 activity
(Fig. 3A). Palmitic acid is one of the most prevalent fatty acids
in plasma and might activate important signaling mechanisms
in pancreatic islets for maintenance of A cell mass.
In conclusion, we reported herein that palmitate exposure
for a short period increased IRS2 Tyr phosphorylation and PI3K
activity and caused a delay of ERK and STAT3 dephosphory-
lation. Thus, palmitate at physiological concentration range may
play an important role to preserve the pancreatic A cell ma-
chinery and function.
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